This is an update on advances in lung cancer. The book examines advances in the treatment and prevention of lung cancer, looking at developments in chemotherapeutic drugs and drug combinations, which have resulted in clinically meaningful improvements in survival of patients with nonsmall cell lung carcinoma. The four chapters devoted to reviewing these drugs look at paclitaxel, docetaxel, vinorelbine, gemcitabine and topoisomerase inhibitors. Advances in the management of locally advanced nonsmall cell lung cancer are considered, including combined-modality treatments using chemotherapy, surgery and radiation therapy, and the results of trials involving chemoprevention agents are also reported. Finally, progress in understanding the molecular biology of this disease and how it might impact on the clinical management of lung cancer patients is discussed.
Book Description
Product Details
Would you like to update product info or give feedback on images?
|
Customer Reviews
|
There are no customer reviews yet.
|
|||
|
Video reviews
|
Tag this product(What's this?)Think of a tag as a keyword or label you consider is strongly related to this product.
Tags will help all customers organize and find favorite items. |
Sell a Digital Version of This Book in the Kindle Store
If you are a publisher or author and hold the digital rights to a book, you can sell a digital version of it in our Kindle Store.
Learn more
Customer Discussions
|
This product's forum
Active discussions in related forums
Search Customer Discussions
|
Related forums
|
